|
1
|
Swanson MS and Dreyfuss G: Classification
and purification of proteins of heterogeneous nuclear
ribonucleoprotein particles by RNA-binding specificities. Mol Cell
Biol. 8:2237–2241. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carpenter B, MacKay C, Alnabulsi A, MacKay
M, Telfer C, Melvin WT and Murray GI: The roles of heterogeneous
nuclear ribonucleoproteins in tumour development and progression.
Biochim Biophys Acta. 1765:85–100. 2006.PubMed/NCBI
|
|
3
|
Evans JR, Mitchell SA, Spriggs KA,
Ostrowski J, Bomsztyk K, Ostarek D and Willis AE: Members of the
poly (rC) binding protein family stimulate the activity of the
c-myc internal ribosome entry segment in vitro and in vivo.
Oncogene. 22:8012–8020. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dejgaard K and Leffers H: Characterisation
of the nucleic-acid-binding activity of KH domains. Different
properties of different domains. Eur J Biochem. 241:425–431. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson SM, Datar KV, Paddy MR, Swedlow JR
and Swanson MS: Characterization of nuclear polyadenylated
RNA-binding proteins in Saccharomyces cerevisiae. J Cell Biol.
127:1173–1184. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Michael WM, Eder PS and Dreyfuss G: The K
nuclear shuttling domain: A novel signal for nuclear import and
nuclear export in the hnRNP K protein. EMBO J. 16:3587–3598. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bomsztyk K, Van Seuningen I, Suzuki H,
Denisenko O and Ostrowski J: Diverse molecular interactions of the
hnRNP K protein. FEBS Lett. 403:113–115. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ostareck-Lederer A, Ostareck DH, Cans C,
Neubauer G, Bomsztyk K, Superti-Furga G and Hentze MW:
c-Src-mediated phosphorylation of hnRNP K drives translational
activation of specifically silenced mRNAs. Mol Cell Biol.
22:4535–4543. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ostareck-Lederer A, Ostareck DH and Hentze
MW: Cytoplasmic regulatory functions of the KH-domain proteins
hnRNPs K and E1/E2. Trends Biochem Sci. 23:409–411. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi HS, Hwang CK, Song KY, Law PY, Wei LN
and Loh HH: Poly(C)-binding proteins as transcriptional regulators
of gene expression. Biochem Biophys Res Commun. 380:431–436. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michelotti EF, Michelotti GA, Aronsohn AI
and Levens D: Heterogeneous nuclear ribonucleoprotein K is a
transcription factor. Mol Cell Biol. 16:2350–2360. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shnyreva M, Schullery DS, Suzuki H, Higaki
Y and Bomsztyk K: Interaction of two multifunctional proteins.
Heterogeneous nuclear ribonucleoprotein K and Y-box-binding
protein. J Biol Chem. 275:15498–15503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takimoto M, Tomonaga T, Matunis M, Avigan
M, Krutzsch H, Dreyfuss G and Levens D: Specific binding of
heterogeneous ribonucleoprotein particle protein K to the human
c-myc promoter, in vitro. J Biol Chem. 268:18249–18258.
1993.PubMed/NCBI
|
|
14
|
Samuel SK, Spencer VA, Bajno L, Sun JM,
Holth LT, Oesterreich S and Davie JR: In situ cross-linking by
cisplatin of nuclear matrix-bound transcription factors to nuclear
DNA of human breast cancer cells. Cancer Res. 58:3004–3008.
1998.PubMed/NCBI
|
|
15
|
Biscardi JS, Tice DA and Parsons SJ:
c-Src, receptor tyrosine kinases, and human cancer. Adv Cancer Res.
76:61–119. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jacobs C and Rübsamen H: Expression of
pp60c-src protein kinase in adult and fetal human tissue: High
activities in some sarcomas and mammary carcinomas. Cancer Res.
43:1696–1702. 1983.PubMed/NCBI
|
|
17
|
Bonham K, Ritchie SA, Dehm SM, Snyder K
and Boyd FM: An alternative, human SRC promoter and its regulation
by hepatic nuclear factor-1alpha. J Biol Chem. 275:37604–37611.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du Q, Melnikova IN and Gardner PD:
Differential effects of heterogeneous nuclear ribonucleoprotein K
on Sp1- and Sp3-mediated transcriptional activation of a neuronal
nicotinic acetylcholine receptor promoter. J Biol Chem.
273:19877–19883. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ritchie S, Boyd FM, Wong J and Bonham K:
Transcription of the human c-Src promoter is dependent on Sp1, a
novel pyrimidine binding factor SPy, and can be inhibited by
triplex-forming oligonucleotides. J Biol Chem. 275:847–854. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ritchie SA, Pasha MK, Batten DJ, Sharma
RK, Olson DJ, Ross AR and Bonham K: Identification of the SRC
pyrimidine-binding protein (SPy) as hnRNP K: Implications in the
regulation of SRC1A transcription. Nucleic Acids Res. 31:1502–1513.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barboro P, D'Arrigo C, Diaspro A, Mormino
M, Alberti I, Parodi S, Patrone E and Balbi C: Unraveling the
organization of the internal nuclear matrix: RNA-dependent
anchoring of NuMA to a lamin scaffold. Exp Cell Res. 279:202–218.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ostrowski J, Kawata Y, Schullery DS,
Denisenko ON and Bomsztyk K: Transient recruitment of the hnRNP K
protein to inducibly transcribed gene loci. Nucleic Acids Res.
31:3954–3962. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saitoh N, Spahr CS, Patterson SD, Bubulya
P, Neuwald AF and Spector DL: Proteomic analysis of interchromatin
granule clusters. Mol Biol Cell. 15:3876–3890. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barboro P, D'Arrigo C, Repaci E, Bagnasco
L, Orecchia P, Carnemolla B, Patrone E and Balbi C: Proteomic
analysis of the nuclear matrix in the early stages of rat liver
carcinogenesis: Identification of differentially expressed and
MAR-binding proteins. Exp Cell Res. 315:226–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barboro P, Repaci E, D'Arrigo C and Balbi
C: The role of nuclear matrix proteins binding to matrix attachment
regions (Mars) in prostate cancer cell differentiation. PLoS One.
7:e406172012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marenduzzo D, Faro-Trindade I and Cook PR:
What are the molecular ties that maintain genomic loops? Trends
Genet. 23:126–133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barboro P, Borzì L, Repaci E, Ferrari N
and Balbi C: Androgen receptor activity is affected by both nuclear
matrix localization and the phosphorylation status of the
heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated
LNCaP cells. PLoS One. 8:e792122013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen K, Dai X and Wu J: Alternative
splicing: An important mechanism in stem cell biology. World J Stem
Cells. 7:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lanave C, Santamaria M and Saccone C:
Comparative genomics: The evolutionary history of the Bcl-2 family.
Gene. 333:71–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Revil T, Pelletier J, Toutant J, Cloutier
A and Chabot B: Heterogeneous nuclear ribonucleoprotein K represses
the production of pro-apoptotic Bcl-xS splice isoform. J Biol Chem.
284:21458–21467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wahl MC, Will CL and Lührmann R: The
spliceosome: Design principles of a dynamic RNP machine. Cell.
136:701–718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan Q, Shai O, Lee LJ, Frey BJ and
Blencowe BJ: Deep surveying of alternative splicing complexity in
the human transcriptome by high-throughput sequencing. Nat Genet.
40:1413–1415. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lynch M, Chen L, Ravitz MJ, Mehtani S,
Korenblat K, Pazin MJ and Schmidt EV: hnRNP K binds a core
polypyrimidine element in the eukaryotic translation initiation
factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes
to neoplastic transformation. Mol Cell Biol. 25:6436–6453. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yano M, Okano HJ and Okano H: Involvement
of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal
differentiation through p21 mRNA post-transcriptional regulation. J
Biol Chem. 280:12690–12699. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Notari M, Neviani P, Santhanam R, Blaser
BW, Chang JS, Galietta A, Willis AE, Roy DC, Caligiuri MA, Marcucci
G, et al: A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential
by regulating MYC mRNA translation. Blood. 107:2507–2516. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ostrowski J, Schullery DS, Denisenko ON,
Higaki Y, Watts J, Aebersold R, Stempka L, Gschwendt M and Bomsztyk
K: Role of tyrosine phosphorylation in the regulation of the
interaction of heterogenous nuclear ribonucleoprotein K protein
with its protein and RNA partners. J Biol Chem. 275:3619–3628.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jeon HK, Ahn JH, Choe J, Park JH and Lee
TH: Anti-IgM induces up-regulation and tyrosine-phosphorylation of
heterogeneous nuclear ribonucleoprotein K proteins (hnRNP K) in a
Ramos B cell line. Immunol Lett. 98:303–310. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bustelo XR, Suen KL, Michael WM, Dreyfuss
G and Barbacid M: Association of the vav proto-oncogene product
with poly(rC)-specific RNA-binding proteins. Mol Cell Biol.
15:1324–1332. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Groysman M, Nagano M, Shaanan B and Katzav
S: Mutagenic analysis of Vav reveals that an intact SH3 domain is
required for transformation. Oncogene. 17:1597–1606. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xiao Z, Ko HL, Goh EH, Wang B and Ren EC:
hnRNP K suppresses apoptosis independent of p53 status by
maintaining high levels of endogenous caspase inhibitors.
Carcinogenesis. 34:1458–1467. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mandal M, Vadlamudi R, Nguyen D, Wang RA,
Costa L, Bagheri-Yarmand R, Mendelsohn J and Kumar R: Growth
factors regulate heterogeneous nuclear ribonucleoprotein K
expression and function. J Biol Chem. 276:9699–9704. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mukhopadhyay NK, Kim J, Cinar B,
Ramachandran A, Hager MH, Di Vizio D, Adam RM, Rubin MA,
Raychaudhuri P, De Benedetti A, et al: Heterogeneous nuclear
ribonucleoprotein K is a novel regulator of androgen receptor
translation. Cancer Res. 69:2210–2218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gao R, Yu Y, Inoue A, Widodo N, Kaul SC
and Wadhwa R: Heterogeneous nuclear ribonucleoprotein K (hnRNP-K)
promotes tumor metastasis by induction of genes involved in
extracellular matrix, cell movement, and angiogenesis. J Biol Chem.
288:15046–15056. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Brown GT and Murray GI: Current
mechanistic insights into the roles of matrix metalloproteinases in
tumour invasion and metastasis. J Pathol. 237:273–281. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cell Pharmacol. 3:83–92. 2011.PubMed/NCBI
|
|
47
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gumireddy K, Li A, Yan J, Setoyama T,
Johannes GJ, Orom UA, Tchou J, Liu Q, Zhang L, Speicher DW, et al:
Identification of a long non-coding RNA-associated RNP complex
regulating metastasis at the translational step. EMBO J.
32:2672–2684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang
SZ, Ren XB and Cao S: miR-205 in cancer: An angel or a devil? Eur J
Cell Biol. 92:54–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Szczyrba J, Nolte E, Hart M, Döll C, Wach
S, Taubert H, Keck B, Kremmer E, Stöhr R, et al: Identification of
ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are
downregulated in prostate carcinoma. Int J Cancer. 132:775–784.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Szczyrba J, Löprich E, Wach S, Jung V,
Unteregger G, et al: The microRNA profile of prostate carcinoma
obtained by deep sequencing. Mol Cancer Res. 8:529–538. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Carpenter B, McKay M, Dundas SR, Lawrie
LC, Telfer C and Murray GI: Heterogeneous nuclear ribonucleoprotein
K is over expressed, aberrantly localised and is associated with
poor prognosis in colorectal cancer. Br J Cancer. 95:921–927. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Roychoudhury P and Chaudhuri K: Evidence
for heterogeneous nuclear ribonucleoprotein K overexpression in
oral squamous cell carcinoma. Br J Cancer. 97:574–575; author reply
576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Inoue A, Sawata SY, Taira K and Wadhwa R:
Loss-of-function screening by randomized intracellular antibodies:
Identification of hnRNP-K as a potential target for metastasis.
Proc Natl Acad Sci USA. 104:8983–8988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hope NR and Murray GI: The expression
profile of RNA-binding proteins in primary and metastatic
colorectal cancer: Relationship of heterogeneous nuclear
ribonucleoproteins with prognosis. Hum Pathol. 42:393–402. 2011.
View Article : Google Scholar : PubMed/NCBI
|
